Westside Investment Management Inc. Acquires 15,431 Shares of Revvity Inc. $RVTY

Westside Investment Management Inc. acquired a new stake in Revvity Inc. (NYSE:RVTY) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 15,431 shares of the company’s stock, valued at approximately $2,359,000.

A number of other institutional investors have also recently bought and sold shares of RVTY. Kestra Advisory Services LLC raised its stake in shares of Revvity by 3.4% during the 3rd quarter. Kestra Advisory Services LLC now owns 10,602 shares of the company’s stock worth $1,621,000 after purchasing an additional 352 shares during the period. Commonwealth Equity Services LLC boosted its holdings in shares of Revvity by 3.3% in the 3rd quarter. Commonwealth Equity Services LLC now owns 11,491 shares of the company’s stock worth $1,757,000 after buying an additional 365 shares during the last quarter. Chicago Partners Investment Group LLC grew its position in Revvity by 6.8% during the third quarter. Chicago Partners Investment Group LLC now owns 3,922 shares of the company’s stock valued at $623,000 after buying an additional 251 shares during the period. Rakuten Investment Management Inc. grew its position in Revvity by 8.0% during the third quarter. Rakuten Investment Management Inc. now owns 12,773 shares of the company’s stock valued at $1,951,000 after buying an additional 945 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. grew its position in Revvity by 35.4% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 67,485 shares of the company’s stock valued at $10,318,000 after buying an additional 17,629 shares during the period. Institutional investors own 86.65% of the company’s stock.

Revvity Stock Performance

Shares of RVTY stock opened at $151.12 on Friday. The stock has a market capitalization of $16.86 billion, a P/E ratio of 66.87, a PEG ratio of 2.80 and a beta of 1.08. The company has a current ratio of 2.65, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36. The firm’s 50 day moving average is $147.08 and its 200 day moving average is $113.03. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $171.74.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $1.38 EPS for the quarter, topping the consensus estimate of $1.30 by $0.08. Revvity had a net margin of 8.61% and a return on equity of 8.64%. The company had revenue of $728.90 million during the quarter, compared to the consensus estimate of $694.73 million. During the same period last year, the firm earned $1.18 EPS. Revvity’s revenue for the quarter was up 4.3% on a year-over-year basis. On average, sell-side analysts anticipate that Revvity Inc. will post 5.42 earnings per share for the current year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 12th. Stockholders of record on Friday, January 22nd will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 22nd. Revvity’s dividend payout ratio (DPR) is presently 12.39%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on RVTY. Weiss Ratings upgraded shares of Revvity from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. TD Cowen upped their price objective on Revvity from $175.00 to $185.00 and gave the company a “buy” rating in a research note on Wednesday. Bank of America reiterated a “neutral” rating on shares of Revvity in a research note on Wednesday. Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Finally, William Blair began coverage on Revvity in a research report on Monday, October 5th. They issued an “outperform” rating for the company. Six research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. According to MarketBeat, Revvity has a consensus rating of “Hold” and an average target price of $133.86.

Insiders Place Their Bets

In other news, insider Tajinder Vohra sold 7,330 shares of Revvity stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total value of $1,032,650.40. Following the completion of the transaction, the insider directly owned 6,635 shares in the company, valued at approximately $934,738.80. The trade was a 52.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Maxwell Krakowiak sold 1,631 shares of Revvity stock in a transaction on Monday, September 21st. The shares were sold at an average price of $144.53, for a total value of $235,728.43. Following the completion of the transaction, the insider owned 14,781 shares of the company’s stock, valued at approximately $2,136,297.93. This trade represents a 9.94% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 9,045 shares of company stock valued at $1,281,439 over the last ninety days. Corporate insiders own 0.85% of the company’s stock.

Key Stories Impacting Revvity

Here are the key news stories impacting Revvity this week:

• Positive Sentiment: Revvity reported adjusted earnings of $1.38 per share, beating the $1.30 consensus, while revenue of $728.9 million also exceeded expectations and grew 4.3% year over year. Coverage highlighted AI-related demand and operational execution as growth drivers. RVTY Q3 deep dive: AI demand and operational execution drive broad-based growth
• Positive Sentiment: CFRA upgraded the shares from Hold to Buy. TD Cowen also maintained a Buy rating and raised its price target to $185 from $175, while Barclays lifted its target to $175 from $160. TD Cowen recommendations
• Neutral Sentiment: JPMorgan raised its price target to $160 from $155 but kept a Neutral rating. RBC raised its target sharply, to $172 from $135, while retaining Sector Perform. These target increases suggest improved expectations, but the ratings signal caution from some firms. JPMorgan recommendations
• Negative Sentiment: Despite the earnings beat, coverage raised the question of whether the stock is now too expensive. Its elevated valuation could limit upside or make the shares vulnerable to profit-taking after reaching a one-year high. Revvity reaffirms its dividend: Is the stock now too pricey?

Revvity Profile

Revvity, Inc provides technology, products and services for the life sciences and diagnostics markets. The company supports pharmaceutical and biotechnology research, clinical laboratories and other healthcare organizations with tools used in drug discovery, biological research, disease detection and laboratory testing.

Its offerings include laboratory instruments, reagents, consumables, software and workflow solutions. Key areas include genomics, proteomics, cellular analysis, imaging, screening, automation and reproductive health, as well as newborn screening and other diagnostic applications.